Platelet activation in diabetic microangiopathy

Platelets

Volumn 9, Issue 3-4, 1998, Pages 237-240

  Rauch, U ^b,c   Schwippert, B ^a   Schultheiss, H P ^b   Tschoepe, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PADGEM PROTEIN; THROMBOSPONDIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROANGIOPATHY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0031809496     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876762     Document Type: Conference Paper

References (9)

1. National Diabetes Data Group. Diabetes in America: diabetes data compiled 1984. Bethesda, Md.: National Institutes of Health, (NIH publication no. 85-1468), 1985.
2. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992; 41 (suppl. 2): 26-31
3. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 1995; 44: 890-4
4. Tschoepe D, Schultheiss HP, Kolarov P, Schwippert B, Dannehl K, Nieuwebhuis HK, et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
5. Valet G, Valet M, Tschoepe D, Gabriel H, Rothe G, Kellermann W, et al. White cell and thrombocyte disorders. Standardized, self-learning flow cytometric list mode data classification with the CLASSIF1 program system. Ann NY Acad Sci 1993; 677: 233-51.
6. Nieuwenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with monoclonal antibody against activated platelets: evidence that a secreted 53 000-molecular weight lysosome-like α-granute protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838-45.
7. Winocour PD, Laimins M, Colwell JA. Platelet survival in striptozotocin-induced diabetic rats. Thromb Haemostas 1984; 51: 307-11.
8. Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte cross-talk in diabetes mellitus. Horm Metab Res, 1997, 29: 631-35.
9. Rauch U, Hesse S, Schwippert B, Tschoepe D. Leukocyte-platelet co-aggregation hallmarks the severity of diabetic microangiopathy. Diabetes 1996; 45 (suppl. 2): 974.